PLAU antibody (C-Term)
Quick Overview for PLAU antibody (C-Term) (ABIN185470)
Target
See all PLAU AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- Plasminogen Activator / PLAU
-
Sequence
- HFLPWIRSHT KEEN
-
Specificity
- This antibody is expected to recognise both reported isoforms.
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-HFLPWIRSHTKEEN, from the C Terminus of the protein sequence according to NP_002649.1, NP_001138503.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: Paraffin embedded Human Prostate and Placenta. Recommended concentration: 8 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:16000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Alternative Name
- Plasminogen Activator / PLAU
-
Background
- PLAU, plasminogen activator, urokinase, HGNC:9052, ATF, UPA, URK, u-PA , U-plasminogen activator, antagonist of uPA, plasminogen activator, urinary, urokinase plasminogen activator, urokinase-type plasminogen activator amino-terminal, urokinase-type plasm
-
Gene ID
- 5328
-
NCBI Accession
- NP_002649, NP_001138503
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Target
-